Previous 10 | Next 10 |
Fluidigm (FLDM): Q1 Non-GAAP EPS of -$0.15 misses by $0.11; GAAP EPS of -$0.25 misses by $0.11.Revenue of $32.8M (+18.8% Y/Y) beats by $0.83M.Q2 2021 Guidance: Product and service revenue of approximately $29 million to $31 million, or approximately 29 percent to 38 percent year-over-yea...
Forecasting underlying base business growth of 16–17% supported by new product innovation SOUTH SAN FRANCISCO, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through com...
SOUTH SAN FRANCISCO, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the publication of data that further validate the potential o...
I stick to my best-performing screens but with a grain of salt, and I am waiting for an entry point. I simplify the charts to make my decisions quicker and save mental energy. Fundamentals always rule: There must be revenue growth that justify the price appreciation. For fur...
SOUTH SAN FRANCISCO, Calif., April 08, 2021 (GLOBE NEWSWIRE) -- Fluidigm Corporation (Nasdaq:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced that it will report first quarter 2021 financial resul...
FinancialBuzz.com News Commentary New York, NY (3/31/2021) – The pandemic is still a very real threat as the number of new cases spiked in the United States once again. Data provided by Johns Hopkins University indicates that U.S has averaged 65,700 new cases a day over the last ...
Glenview Capital Management’s 13F portfolio value increased from $3.19B to $4.36B this quarter. The number of positions increased from 45 to 54. They increased Lyft Inc. & Boston Scientific while reducing Meritor and Hologic during the quarter. The top three stakes are ...
The FDA grants Emergency Use Authorization to Fluidigm's (FLDM) AZOVA COVID-19 Test Collection Kit for use with the Fluidigm Advanta Dx SARS-CoV-2 RT-PCR Assay on the company’s Biomark HD platform.The Advanta Dx SARS-CoV-2 RT-PCR Assay is an extraction-free saliva-based test to detect ...
Collaboration Agreement to Market AZOVA COVID-19 Test Collection Kit Online AZOVA Digital Health Platform Provides Patient Questionnaire, Process for Prescription, Kit Purchase, Sample Collection, and Secure Delivery of Test Results SOUTH SAN FRANCISC...
Stock market indices stand to finish mixed after a holiday-shortened week where Congressional hearings around GameStop (GME) dominated headlines. The Nasdaq (COMP) may eke out a small gain for the week, while the S&P 500 (SP500) is down about 0.8% at the time of this writing. Dow Industri...
News, Short Squeeze, Breakout and More Instantly...
SOUTH SAN FRANCISCO, Calif., July 17, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (“Standard BioTools” or the “Company”) (Nasdaq: LAB) today announced that it will report second quarter 2024 financial results on Wednesday, July 31, 2024, after the close of the...
SOUTH SAN FRANCISCO, Calif and SALT LAKE CITY, May 28, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (Nasdaq:LAB) today announced that it has purchased the LSA XT system from Carterra ® , a leading provider of high-throughput large and small molecule screening and characteriza...
Ahead of plan on operating expense synergies; $50 million of $80 million target to be achieved by year-end 2024 with remaining balance in FY2025 Delivered pro forma combined revenue of $46.2 million, gross margin of 49.2%, non-GAAP gross margin of 56.3%, operating expense reduction of app...